Sabra Health Care REIT
SBRA
#3051
Rank
HK$31.19 B
Marketcap
HK$131.86
Share price
1.37%
Change (1 day)
17.42%
Change (1 year)

P/E ratio for Sabra Health Care REIT (SBRA)

P/E ratio as of December 2024 (TTM): -31.4

According to Sabra Health Care REIT's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -31.4496. At the end of 2022 the company had a P/E ratio of -36.6.

P/E ratio history for Sabra Health Care REIT from 2011 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-36.637.7%
2021-26.5-202.41%
202025.9-58.69%
201962.8478.9%
201810.8-30.68%
201715.6-41.07%
201626.546.95%
201518.1-58.37%
201443.412.86%
201338.4-6.2%
201241.045.76%
201128.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
-8.88-71.75%๐Ÿ‡บ๐Ÿ‡ธ USA
13.2-141.97%๐Ÿ‡บ๐Ÿ‡ธ USA
22.6-171.84%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.